• 2023年10月热销股票

    23rd November, 2023

    摘要: 来POEMS开始交易吧! 在这里免费开户! 市场概览: 以色列和哈马斯爆发冲突导致油价上涨 美联储(FED) 承诺维持2%的通胀目标,将利率维持在5.25%至5.5%的区间内 10年期美国国债收益率触及5%,为16年来的高位,随后开始回落 NFLX限制密码分享的举措,促进了用户增长 10月,三大股指连续3个月下跌。 纳斯...

    更多
  • 2023年9月热销股票

    27th October, 2023

    摘要: 来POEMS开始交易吧! 在这里免费开户! 市场概览: 油价上涨 美联储维持利率不变,预计年底前会再加息一次 10年期美国国债收益率触及16年来的高位 美元达到10个月高点 ARM 和CART IPO首日大涨 随着美联储展现鹰派立场,三大股指继续走低。 纳斯达克 道琼斯 标普500 月开盘 14,...

    更多
  • 2023年8月热销股票

    28th September, 2023

    摘要: 来POEMS开始交易吧! 在这里免费开户! 市场概览: 美国债务评级下调至AA+ 年底加息的可能性 美联储加息0.25% 中国下调关键政策利率 中国北京下调交易印花税 亚马逊的成本削减举措奏效 三大股指齐跌,打破了数月来的上涨势头。 纳斯达克 道琼斯 标普500 月开盘 14,274.93...

    更多
  • 2023年7月热销股票

    28th August, 2023

    摘要: 来POEMS开始交易吧!在这里免费开户 ! 市场概览:  6月份的年度CPI为3%,是两年来的最低水平 美联储加息0.25% GM第二次上调了2023年的预期指引 美国联邦贸易委员会叫停微软收购美国动视的交易请求遭到拒绝   市场看涨趋势持续,纳斯达克和标普500指数连续五个月上涨,而道琼斯指数连续两个月上涨。 纳斯达克 ...

    更多
  • 新加坡 | 综合企业 | 2020财年汇报

    3rd February, 2021

    摘要: 2020财年的营收和利润分别为35亿新元和1500万新元,业绩超过我们的预期。 吉宝O&M(运营与维护)重组为三个部门(分别是Op co, Rig co 和Dev co),而Rigco着眼于潜在的撤资或盈利。 仍有望在未来三年内释放30-50亿新元的资产,目前已宣布释放的资产规模达到了12亿新元。15%的净资产收益率目标已确认。 维持买入评级,按SOTP计算的目标价为12...

    更多
  • 辉立宏观经济分析: 美国大选: 市场和行业概览

    16th November, 2020

    摘要: 选举日前后的历史市场表现 选举日前夕。在过去的选举年(1980-2016)期间,2008年除外,在选举日前一个月,S&P 500(标准普尔500)平均上涨了0.73%,而在选举日前一周的平均涨幅达到0.99%(图1)。考虑到新冠疫情卷土重来引发的市场动荡,财政刺激措施的延迟,以及对选举结果充满争议或延迟的风险,我们认为类似的规律今年将不会重演。这是自1980年以来,第二次在选举期间,...

    更多
  • 腾飞房产信托: 业绩企稳

    16th November, 2020

    摘要: 2020年三季度,投资组合恢复至 -2.3%,但入住率从91.5%微升至91.9%。由于2020上半年的租赁表现强劲,2020财年末仍可实现低个位数的正回归,这与我们的租金回归预测一致。 规模和多样化的租户组合缓解了疲弱的行业前景。除新加坡的投资组合外,没有提前终止:9个租户,占NLA的1,800平方米。 上调至买入评级,使用DDM(股利贴现模型)计算的目标价从3.63新元下调至3.6...

    更多
  • 美国大选后焦点(1/2):疫苗带来一线曙光

    16th November, 2020

    摘要: 选举后的动向会是什么呢? 选举后,美国新冠肺炎的病例继续激增。拜登已成立一个特别工作组来负责控制疫情。但这些举措,他只有在明年1月下旬正式上任后才能执行。与此同时,比起控制疫情,特朗普可能更专注于对选举结果产生的争议。由于到那时为止,几乎没有任何措施到位,病例可能会进一步升级。   病毒死灰复燃可能令情况更糟糕 - 疫苗成为焦点 敢问路在何方?每周新增病例的百...

    更多
  • 技术脉冲分析

    4th November, 2020

    摘要: 小米公司 (港交所代码:1810) 强劲的看涨中波段尚未完成,而当前的波段分析显示,小米目前正处于修正的第四波段,技术面显示该股有进一步上涨的潜力: 波段分析表明,小米的第三波是一个延长波,因此第四波的修正作用将可能是修正复杂的平面。 子波(w)(x)(y)的下降楔形,实际上是在A波段上发现的较大的下降楔形的分形版本。因此,下一波上行的行情有机会跟进。 看涨的外柱试图打破下降...

    更多
  • 2020美国大选对医疗板块影响

    20th October, 2020

    摘要: 提纲概述: • 药品成本紧紧抓住美国选民的心。两位总统候选人都明白这一点,并承诺会降低医疗成本。 • 如果特朗普胜出,预计制药和医疗保险类股会上涨 • 如果拜登获胜,预计医疗保健提供商和生物科技类股将成为赢家。 • 无论谁获胜,行业前景乐观。 • 对药品利润的影响,可能会被对医疗保险覆盖面的扩大,以及加大对先进医疗技术研发资金的投入所抵消。   1. 药品价格 ...

    更多

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com